Ziopharm

Get Ready for More Acquisitions by Gilead Sciences
Get Ready for More Acquisitions by Gilead Sciences
Motley Fool
Gilead Sciences
M&A
Kite Pharma
Ziopharm
Flag link:
FDA Allows Ziopharm Brain Cancer Drug Trial
FDA Allows Ziopharm Brain Cancer Drug Trial
Investopedia
FDA
Ziopharm
brain cancer
clinical trials
Ad-RTS-hIL-12
glioblastoma
Flag link:
4 Cancer Drug Developers You Need to Have on Your Radar This Year
4 Cancer Drug Developers You Need to Have on Your Radar This Year
Motley Fool
cancer
Exelixis
Celldex Therapeutics
Ziopharm
Jazz Pharmaceuticals
Flag link:
Here are 13 MA cancer biotechs hoping to make waves next month
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
Flag link:
Is ZIOPHARM Poised For Acquisition?
Is ZIOPHARM Poised For Acquisition?
Seeking Alpha
Ziopharm
M&A
Intrexon
Flag link:
Who Is Gilead Going To Buy?
Who Is Gilead Going To Buy?
Seeking Alpha
Gilead Sciences
M&A
Genfit
Intercept Pharma
Agios Pharmaceuticals
Ziopharm
Flag link:
Top 4 Biopharma Movers of the Past Week
Top 4 Biopharma Movers of the Past Week
24/7 Wall St
Trevena
Ziopharm
Radius Health
Valeant Pharmaceuticals
Flag link:
3 Biotech Stocks That Could Be Buyout Targetst
3 Biotech Stocks That Could Be Buyout Targetst
Motley Fool
Intrexon
Ziopharm
Bluebird Bio
Biomarin
Flag link:
Here’s why some investors think Ziopharm is poised for a $10B merger
Here’s why some investors think Ziopharm is poised for a $10B merger
Bizjournals.com
M&A
Ziopharm
Flag link:
Four one-time biotech underdogs are outperforming the market this year
Four one-time biotech underdogs are outperforming the market this year
Bizjournals.com
biotech
Aveo Oncology
Foundation Medicine
InVivo
Ziopharm
Flag link:
Ziopharm Oncology posts 4th-quarter loss of $10.4 million
Ziopharm Oncology posts 4th-quarter loss of $10.4 million
Yahoo/AP
Ziopharm
earnings
Flag link:
The 3 Best Biotech Stocks Of The Last 30 Days
The 3 Best Biotech Stocks Of The Last 30 Days
Yahoo/Benzinga
Array Biopharma
Tekmira
Ziopharm
Flag link:
Kite Pharma/Amgen: A Strong Combination
Kite Pharma/Amgen: A Strong Combination
Seeking Alpha
Kite Pharma
Amgen
Juno Therapeutics
Bellicum
Ziopharm
CAR-T
Flag link:
Ziopharm posts 3Q loss
Ziopharm posts 3Q loss
Yahoo/AP
earnings
Ziopharm
Flag link:
The Sirens of Ziopharm
The Sirens of Ziopharm
Seeking Alpha
sarcoma
oncology
Ziopharm
Flag link:
ZIOPHARM Presents Encouraging Data
ZIOPHARM Presents Encouraging Data
Yahoo/Zacks
Ziopharm
Ad-RTS-IL-1
brain cancer
Flag link:
Five Small Biotech Stocks Analysts Think Will Triple
Five Small Biotech Stocks Analysts Think Will Triple
Forbes
Arrowhead Research
ChemoCentryx
Ziopharm
TherapeuticsMD
Dynavax
Flag link:
Ziopharm: Attempting To Rise Again In A Crowded Space
Ziopharm: Attempting To Rise Again In A Crowded Space
Seeking Alpha
Ziopharm
Flag link:
The 10 Most Heavily Shorted Bio-Pharma Stocks
The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Spectrum Pharmaceuticals
Dendreon
Achillion
Ziopharm
Intrexon
Arena Pharmaceuticals
Idenix
Synta Pharmaceuticals
Sarepta Therapeutics
Myriad Genetics
Flag link:
The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind
The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind
Motley Fool
Myriad Genetics
Questcor
Ziopharm
Sarepta Therapeutics
MannKind
Flag link: